Why drug approval in Canada should not rely on foreign regulators

Why drug approval in Canada should not rely on foreign regulators

Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day consultation period on using the decisions of foreign drug regulators such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to approve new drugs in Canada. If the proposal is approved, Health Canada will evaluate reports from the other regulators, and provided those reports are satisfact…